Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Mizuho Financial Group $2.5 billion senior notes offering
The senior callable fixed-to-fixed reset rate notes are due 2029 and 2034
Province of British Columbia $2.25 billion global bond offering
The bonds are due 2033
NKT DKK 2.7 billion rights offering
The new shares are listed on Nasdaq Copenhagen
Nextracker $662.5 million common stock offering
We advised Nextracker on the SEC-registered secondary offering
Vesta $445.6 million U.S. IPO
We advised Vesta on its U.S. IPO and NYSE listing
Bausch + Lomb $1.75 billion financing for acquisition of certain Novartis assets
We are advising Bausch + Lomb on the financing
Trinity Industries $400 million senior notes offering
We advised Trinity Industries on its high-yield debt offering
Lucid Group $232 million strategic supply agreement with Aston Martin
We are advising Lucid Group on the transaction
Digicel enters into RSAs to restructure more than $4.4 billion of funded debt
We are advising Digicel in connection with the restructuring
Export Development Canada $2 billion global bond offering
The investment-grade bonds are due 2026